Global Hereditary Angioedema Treatment Sales Market Report 2021

1 Hereditary Angioedema Treatment Market Overview

• 1.1 Hereditary Angioedema Treatment Product Scope
• 1.2 Hereditary Angioedema Treatment Segment by Type
  • 1.2.1 Global Hereditary Angioedema Treatment Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
  • 1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
  • 1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
  • 1.2.5 Others (Conventional Drugs, Pipeline Drugs)
• 1.3 Hereditary Angioedema Treatment Segment by Application
  • 1.3.1 Global Hereditary Angioedema Treatment Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Others (online pharmacies, mail pharmacies)
• 1.4 Hereditary Angioedema Treatment Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Hereditary Angioedema Treatment Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Hereditary Angioedema Treatment Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Hereditary Angioedema Treatment Price Trends (2016-2027)

2 Hereditary Angioedema Treatment Estimates and Forecasts by Region

• 2.1 Global Hereditary Angioedema Treatment Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Hereditary Angioedema Treatment Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2016-2021)
• 2.3 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Hereditary Angioedema Treatment Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
  • 2.4.2 Europe Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
  • 2.4.3 China Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
  • 2.4.4 Japan Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
  • 2.4.6 India Hereditary Angioedema Treatment Estimates and Projections (2016-2027)

3 Global Hereditary Angioedema Treatment Competition Landscape by Players

• 3.1 Global Top Hereditary Angioedema Treatment Players by Sales (2016-2021)
• 3.2 Global Top Hereditary Angioedema Treatment Players by Revenue (2016-2021)
• 3.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2020)
• 3.4 Global Hereditary Angioedema Treatment Average Price by Company (2016-2021)
• 3.5 Manufacturers Hereditary Angioedema Treatment Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Hereditary Angioedema Treatment Market Size by Type

• 4.1 Global Hereditary Angioedema Treatment Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Hereditary Angioedema Treatment Price by Type (2016-2021)
• 4.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Hereditary Angioedema Treatment Price Forecast by Type (2022-2027)

5 Global Hereditary Angioedema Treatment Market Size by Application

• 5.1 Global Hereditary Angioedema Treatment Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Hereditary Angioedema Treatment Price by Application (2016-2021)
• 5.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2022-2027)

6 North America Hereditary Angioedema Treatment Market Facts & Figures

• 6.1 North America Hereditary Angioedema Treatment Sales by Company
  • 6.1.1 North America Hereditary Angioedema Treatment Sales by Company (2016-2021)
  • 6.1.2 North America Hereditary Angioedema Treatment Revenue by Company (2016-2021)
• 6.2 North America Hereditary Angioedema Treatment Sales Breakdown by Type
  • 6.2.1 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
• 6.3 North America Hereditary Angioedema Treatment Sales Breakdown by Application
  • 6.3.1 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2022-2027)

7 Europe Hereditary Angioedema Treatment Market Facts & Figures

• 7.1 Europe Hereditary Angioedema Treatment Sales by Company
  • 7.1.1 Europe Hereditary Angioedema Treatment Sales by Company (2016-2021)
  • 7.1.2 Europe Hereditary Angioedema Treatment Revenue by Company (2016-2021)
• 7.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type
  • 7.2.1 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
• 7.3 Europe Hereditary Angioedema Treatment Sales Breakdown by Application
  • 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Hereditary Angioedema Treatment Market Facts & Figures

• 8.1 China Hereditary Angioedema Treatment Sales by Company
  • 8.1.1 China Hereditary Angioedema Treatment Sales by Company (2016-2021)
  • 8.1.2 China Hereditary Angioedema Treatment Revenue by Company (2016-2021)
• 8.2 China Hereditary Angioedema Treatment Sales Breakdown by Type
  • 8.2.1 China Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
• 8.3 China Hereditary Angioedema Treatment Sales Breakdown by Application
  • 8.3.1 China 244 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Hereditary Angioedema Treatment Market Facts & Figures

• 9.1 Japan Hereditary Angioedema Treatment Sales by Company
  • 9.1.1 Japan Hereditary Angioedema Treatment Sales by Company (2016-2021)
  • 9.1.2 Japan Hereditary Angioedema Treatment Revenue by Company (2016-2021)
• 9.2 Japan Hereditary Angioedema Treatment Sales Breakdown by Type
  • 9.2.1 Japan Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
• 9.3 Japan Hereditary Angioedema Treatment Sales Breakdown by Application
  • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Hereditary Angioedema Treatment Market Facts & Figures

• 10.1 Southeast Asia Hereditary Angioedema Treatment Sales by Company
  • 10.1.1 Southeast Asia Hereditary Angioedema Treatment Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Hereditary Angioedema Treatment Revenue by Company (2016-2021)
• 10.2 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type
  • 10.2.1 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Hereditary Angioedema Treatment Market Facts & Figures

• 11.1 India Hereditary Angioedema Treatment Sales by Company
  • 11.1.1 India Hereditary Angioedema Treatment Sales by Company (2016-2021)
  • 11.1.2 India Hereditary Angioedema Treatment Revenue by Company (2016-2021)
• 11.2 India Hereditary Angioedema Treatment Sales Breakdown by Type
  • 11.2.1 India Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
• 11.3 India Hereditary Angioedema Treatment Sales Breakdown by Application
  • 11.3.1 India Hereditary Angioedema Treatment Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Hereditary Angioedema Treatment Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Hereditary Angioedema Treatment Business

• 12.1 CSL
  • 12.1.1 CSL Corporation Information
  • 12.1.2 CSL Business Overview
  • 12.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 CSL Hereditary Angioedema Treatment Products Offered
  • 12.1.5 CSL Recent Development
• 12.2 Pharming Group
  • 12.2.1 Pharming Group Corporation Information
  • 12.2.2 Pharming Group Business Overview
  • 12.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
  • 12.2.5 Pharming Group Recent Development
• 12.3 Shire plc (Takeda Pharmaceutical Company Limited)
  • 12.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
  • 12.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
  • 12.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
  • 12.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
• 12.4 Ionis Pharmaceuticals
  • 12.4.1 Ionis Pharmaceuticals Corporation Information
  • 12.4.2 Ionis Pharmaceuticals Business Overview
  • 12.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
  • 12.4.5 Ionis Pharmaceuticals Recent Development
• 12.5 Attune Pharmaceuticals
  • 12.5.1 Attune Pharmaceuticals Corporation Information
  • 12.5.2 Attune Pharmaceuticals Business Overview
  • 12.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
  • 12.5.5 Attune Pharmaceuticals Recent Development
• 12.6 BioCryst Pharmaceuticals
  • 12.6.1 BioCryst Pharmaceuticals Corporation Information
  • 12.6.2 BioCryst Pharmaceuticals Business Overview
  • 12.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
  • 12.6.5 BioCryst Pharmaceuticals Recent Development
• 12.7 KalVista Pharmaceuticals
  • 12.7.1 KalVista Pharmaceuticals Corporation Information
  • 12.7.2 KalVista Pharmaceuticals Business Overview
  • 12.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
  • 12.7.5 KalVista Pharmaceuticals Recent Development

...

13 Hereditary Angioedema Treatment Manufacturing Cost Analysis

• 13.1 Hereditary Angioedema Treatment Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
• 13.4 Hereditary Angioedema Treatment Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Hereditary Angioedema Treatment Distributors List
• 14.3 Hereditary Angioedema Treatment Customers

15 Market Dynamics

• 15.1 Hereditary Angioedema Treatment Market Trends
• 15.2 Hereditary Angioedema Treatment Drivers
• 15.3 Hereditary Angioedema Treatment Market Challenges
• 15.4 Hereditary Angioedema Treatment Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List